Congenital heart disease, pulmonary arterial hypertension and the UK’s Drivers and Vehicle Licensing Agency: controversial new guidance

Detalles Bibliográficos
Autores principales: Constantine, Andrew, Tulloh, Robert, Condliffe, Robin, Clift, Paul, Dimopoulos, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822195/
https://www.ncbi.nlm.nih.gov/pubmed/31695906
http://dx.doi.org/10.1177/2045894019882627
_version_ 1783464289510621184
author Constantine, Andrew
Tulloh, Robert
Condliffe, Robin
Clift, Paul
Dimopoulos, Konstantinos
author_facet Constantine, Andrew
Tulloh, Robert
Condliffe, Robin
Clift, Paul
Dimopoulos, Konstantinos
author_sort Constantine, Andrew
collection PubMed
description
format Online
Article
Text
id pubmed-6822195
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-68221952019-11-06 Congenital heart disease, pulmonary arterial hypertension and the UK’s Drivers and Vehicle Licensing Agency: controversial new guidance Constantine, Andrew Tulloh, Robert Condliffe, Robin Clift, Paul Dimopoulos, Konstantinos Pulm Circ Letter to the Editor SAGE Publications 2019-10-30 /pmc/articles/PMC6822195/ /pubmed/31695906 http://dx.doi.org/10.1177/2045894019882627 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by/4.0/ Creative Commons CC-BY: This article is distributed under the terms of the Creative Commons Attribution 4.0 License (http://www.creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Letter to the Editor
Constantine, Andrew
Tulloh, Robert
Condliffe, Robin
Clift, Paul
Dimopoulos, Konstantinos
Congenital heart disease, pulmonary arterial hypertension and the UK’s Drivers and Vehicle Licensing Agency: controversial new guidance
title Congenital heart disease, pulmonary arterial hypertension and the UK’s Drivers and Vehicle Licensing Agency: controversial new guidance
title_full Congenital heart disease, pulmonary arterial hypertension and the UK’s Drivers and Vehicle Licensing Agency: controversial new guidance
title_fullStr Congenital heart disease, pulmonary arterial hypertension and the UK’s Drivers and Vehicle Licensing Agency: controversial new guidance
title_full_unstemmed Congenital heart disease, pulmonary arterial hypertension and the UK’s Drivers and Vehicle Licensing Agency: controversial new guidance
title_short Congenital heart disease, pulmonary arterial hypertension and the UK’s Drivers and Vehicle Licensing Agency: controversial new guidance
title_sort congenital heart disease, pulmonary arterial hypertension and the uk’s drivers and vehicle licensing agency: controversial new guidance
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822195/
https://www.ncbi.nlm.nih.gov/pubmed/31695906
http://dx.doi.org/10.1177/2045894019882627
work_keys_str_mv AT constantineandrew congenitalheartdiseasepulmonaryarterialhypertensionandtheuksdriversandvehiclelicensingagencycontroversialnewguidance
AT tullohrobert congenitalheartdiseasepulmonaryarterialhypertensionandtheuksdriversandvehiclelicensingagencycontroversialnewguidance
AT condlifferobin congenitalheartdiseasepulmonaryarterialhypertensionandtheuksdriversandvehiclelicensingagencycontroversialnewguidance
AT cliftpaul congenitalheartdiseasepulmonaryarterialhypertensionandtheuksdriversandvehiclelicensingagencycontroversialnewguidance
AT dimopouloskonstantinos congenitalheartdiseasepulmonaryarterialhypertensionandtheuksdriversandvehiclelicensingagencycontroversialnewguidance

Ejemplares similares